David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 11.76% |
| 3 | Healthcare | 10.16% |
| 4 | Financials | 7.89% |
| 5 | Industrials | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Novavax
NVAX
$1.56B
| $778K | ﹤0.01% |
195,393
+168,863
| +636% | +$732K |
|
3102
Safe Bulkers
SB
$886M
| $775K | ﹤0.01% |
455,775
-46,267
| -9% | -$80.4K |
|
3103
Broadridge
BR
$21.1B
| $774K | ﹤0.01% |
6,267
-144
| -2% | -$17.6K |
|
3104
Descartes Systems
DSGX
$6.64B
| $773K | ﹤0.01% |
18,100
-15,500
| -46% | -$632K |
|
3105
PUT
Puma Biotechnology
PBYI
$481M
| $773K | ﹤0.01% |
88,300
| – | – |
|
3106
CALL
Analog Devices
ADI
$181B
| $772K | ﹤0.01% |
6,500
-1,800
| -22% | -$203K |
|
3107
State Street SPDR S&P Pharmaceuticals ETF
XPH
$570M
| $772K | ﹤0.01% |
16,900
| – | – |
|
3108
PUT
Tidewater
TDW
$4.59B
| $771K | ﹤0.01% |
40,000
| – | – |
|
3109
PUT
Wolfspeed
WOLF
$1.31B
| $771K | ﹤0.01% |
16,700
-8,300
| -33% | -$387K |
|
|
TTM
3110
DELISTED
Tata Motors Limited
TTM
| $771K | ﹤0.01% |
59,638
+17,100
| +40% | +$188K |
|
3111
PUT
Cracker Barrel
CBRL
$1.3B
| $769K | ﹤0.01% |
5,000
| – | – |
|
3112
Intrepid Potash
IPI
$509M
| $767K | ﹤0.01% |
28,292
+1,610
| +6% | +$43.7K |
|
3113
Mid-America Apartment Communities
MAA
$15.3B
| $767K | ﹤0.01% |
+5,818
| New | +$779K |
|
3114
Saia
SAIA
$9.17B
| $766K | ﹤0.01% |
8,224
-6,427
| -44% | -$608K |
|
3115
CALL
Ashland
ASH
$3.38B
| $765K | ﹤0.01% |
10,000
| – | – |
|
|
LKFT
3116
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.94B
| $765K | ﹤0.01% |
+3,700
| New | +$684K |
|
|
ARI
3117
Apollo Commercial Real Estate
ARI
$882M
| $763K | ﹤0.01% |
+41,703
| New | +$770K |
|
3118
Nelnet
NNI
$4.61B
| $763K | ﹤0.01% |
13,101
-9,042
| -41% | -$554K |
|
3119
Stock Yards Bancorp
SYBT
$2.49B
| $760K | ﹤0.01% |
18,505
-9,207
| -33% | -$365K |
|
3120
PUT
Commault Systems
CVLT
$5.44B
| $759K | ﹤0.01% |
17,000
| – | – |
|
3121
Autoliv
ALV
$9.08B
| $758K | ﹤0.01% |
+8,983
| New | +$735K |
|
3122
Sensient Technologies
SXT
$5.82B
| $758K | ﹤0.01% |
11,469
-10,959
| -49% | -$702K |
|
|
ACHN
3123
DELISTED
Achillion Pharmaceuticals
ACHN
| $757K | ﹤0.01% |
125,527
-440,992
| -78% | -$2.55M |
|
3124
Delek US
DK
$4.14B
| $755K | ﹤0.01% |
22,522
+15,812
| +236% | +$570K |
|
3125
The RealReal
REAL
$1.35B
| $755K | ﹤0.01% |
+40,063
| New | +$767K |
|
Similar funds
David Shaw's Q4 2019 Portfolio in Review
As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- David Shaw opened 572 new positions and closed 412 in Q4 2019.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.